Further, RIPK1 inhibition suppressed microglial Cst7 expression in an APP/PS1 AD mice model, enhancing the uptake and degradation ability of Aβ-plaques by microglia in AD mice models [80,82]. The gene discussed is APP; the disease is Alzheimer disease.